Global Virus Network improves partnerships among virus researchers

The Global Virus Network (GVN) -- a collaboration of the world’s top medical virology research centers working together to prevent and treat illness and death due to viral disease -- recently hosted its seventh meeting to strengthen the partnerships between virus researchers. Read More »

HIV reservoirs continue to block ultimate cure

Scientists from the National Institutes of Health have noted that there is a need for better understanding of the biology behind HIV reservoirs, which are effectively blocking the researchers’ way to ultimate treatments for the illness. Read More »

Diagnostic errors correlate with wrong antibiotic use

Recent data shows that misdiagnoses and diagnostic errors have led to a higher risk of incorrect antibiotic use, which compromises antimicrobial effectiveness, the patient’s outcomes and the costs of health care. Read More »

Early childhood vaccinations may decrease leukemia risk

A team of researchers from University of California - San Francisco (UCSF) recently conducted a study that suggests early childhood vaccinations may decrease the patients’ risks of developing acute lymphoblastic leukemia (ALL), which is the most common kind of childhood cancer. Read More »

Corium publishes data supporting needle-free transdermal influenza vaccine

A recently published study shows that a needle-free influenza vaccine system called MicroCor effectively delivers the influenza vaccine to patients. Read More »

BriaCell finishes FDA-required testing

BriaCell Therapeutics Corp., a biotechnology company that focuses on immune-oncology and its unique vaccine technology called BriaVax, recently announced it has successfully finished all of the tests the Food and Drug Administration (FDA) requires. Read More »

U.N. agency encourages renewed commitment for HIV vaccine

The Joint United Nations Program on HIV/AIDS, also known as UNAIDS, recently renewed its encouragement for the global health community to sustain its commitment to develop an effective HIV vaccine. Read More »

Rapid TB testing may transform global health care

Scientists recently created a rapid antimicrobial resistance test that allows health professionals to diagnose and treat tuberculosis (TB) faster than ever, which may lead to a transformation of global health care. Read More »

Doctors Without Borders applauds clinical trial for drug-resistant TB treatment

Doctors Without Borders (DWB) has responded favorably to the recent Tuberculosis Alliance (TB) announcement about the launch of its clinical trials for new investigational drugs for XDR-RB, currently the deadliest strain of drug-resistant TB.  Read More »

Medicago to construct new production facility in Canada

Medicago, a leading Canadian biotechnology company and an international developer and manufacturer of plant-based therapeutics and vaccines, recently announced that it will build a new production facility worth $245 million (USD) in Quebec City, Canada. Read More »

Takeda to distribute seasonal flu vaccines in Japan

Takeda Pharmaceutical Co. Ltd. recently announced that it has partnered with the Chemo-Sero-Therapeutic Research Institute to distribute Kaketsuken’s seasonal influenza vaccine throughout Japan. Read More »

Remodeled antibodies may manage HIV

Antibody redesigned with computer shows increased immunity potency Read More »

Phages facilitating antibiotic resistance found in chicken meat

Researchers have recently identified phages transducing antibiotic resistance to bacteria in chicken meat, which means these bacteria pose a serious public health threat.  Read More »

New Ebola treatment increases survival rates in mice

Researchers have shown that an experimental treatment for Ebola increased the survival rates of tested mice as scientists continue searching for ways the global health community can be better prepared for any future outbreaks.   Read More »

World Health Organization approves new global malaria strategy

The World Health Organization (WHO) member states recently approved of the new global malaria strategy for 2016-30 and also approved of the proposed program budget for 2016-17. Read More »

Genocea’s Phase 2 genital herpes test shows positive results

Genocea Biosciences Inc., a biopharmaceutical company that specializes in creating immunotherapies and vaccines for T cells, recently announced positive results from its Phase 2 trial of GEN-003, the company’s new treatment for genital herpes. Read More »

Southeastern Indiana HIV outbreak at 158

Health professionals recently issued the latest update about this year's HIV outbreak in Southeastern Indiana, reporting 157 cases have been confirmed and one additional case has tested as preliminary positive. Read More »

Public health emergency declared in Indiana county after HIV spike

Dr. Jerome Adams, Indiana's state health commissioner,  declared  a state of public health emergency on Thursday in  Scott County, effective through May 24, 2016. The declaration was made in light of the HIV outbreak in Southeastern Indiana. There are now 160 cases of HIV in the area (159 confirmed cases and one case producing a preliminary positive test result). Read More »

Study explores why measles, unlike flu, only requires childhood vaccines

A study recently published in Cell Reports helps shed light on why people only need one vaccine for measles, but multiple vaccines for influenza. The study's conclusion: The proteins on the surface of the measles virus cannot invade the body’s cells if the measles virus has undergone any mutations. Read More »

Chemists discover simple, thrifty method to synthesize amines

A team of chemists from the Scripps Research Institute (TSRI) recently discovered a simple and cost-efficient tool for synthesizing “amines,” which are a specific class of organic compounds that are commonly used in drugs and similar modern products. This discovery is especially useful as a method to synthesize complex amines that are valued in the pharmaceutical industry, but are difficult to synthesize with regular methods. Read More »